Gupta Paridhi, Mahey Reeta, Varun Neha, Kaur Maninder, Kumar Arun, Yadav Satyam
Department of Obstetrics and Gynaecology, AIIMS, New Delhi, India.
J Family Med Prim Care. 2025 Jan;14(1):160-166. doi: 10.4103/jfmpc.jfmpc_780_24. Epub 2025 Jan 13.
To study the knowledge, attitude, and acceptability of Long-acting Reversible Contraceptive (LARC) methods among women attending contraception counselling sessions.
A cross-sectional study conducted in the family planning clinic of a tertiary care hospital.
Women aged 18-45 years attending contraception counselling sessions were included. Baseline knowledge about LARC methods was assessed. They were given information about LARC methods. Acceptability was assessed on a scale of 0-10.
Among four LARC methods, awareness about copper intrauterine devices (CuIUD), DMPA injection, subdermal implant and Mirena was 95%, 55.50%, 27% and 3%, respectively. Around 4% were unaware of the LARC method. Of total, 76.50% women procured the LARC methods information from health care workers, whereas 40% attained from friends, family members, neighbors, or colleagues. After counseling, the majority (58%) were willing for subdermal implant. About 27.50% and 13.50% were willing for copper IUD insertion and injection DMPA, respectively. None was willing for Mirena. Acceptability of various LARC methods was scaled on an acceptability score from 0 to 10. For Cu IUD, implanon and DMPA, the acceptability score was 10 in 50%, 40.17% and 25%, respectively.
There are still gaps of knowledge about benefits and safety of available LARC methods. To improve wide coverage and more acceptability of LARC methods, involvement of health care workers and addition of subdermal implants to contraceptive counseling should be considered.
研究参加避孕咨询门诊的女性对长效可逆避孕(LARC)方法的知识、态度和可接受性。
在一家三级护理医院的计划生育诊所进行的横断面研究。
纳入年龄在18 - 45岁参加避孕咨询门诊的女性。评估她们对LARC方法的基线知识。向她们提供有关LARC方法的信息。可接受性按0至10分进行评估。
在四种LARC方法中,对铜宫内节育器(CuIUD)、醋酸甲羟孕酮注射液、皮下埋植剂和曼月乐的知晓率分别为95%、55.50%、27%和3%。约4%的人不知道LARC方法。总体而言,76.50%的女性从医护人员处获得LARC方法信息,而40%的人从朋友、家人、邻居或同事处获得。咨询后,大多数(58%)愿意接受皮下埋植剂。分别约27.50%和13.50%的人愿意接受铜宫内节育器植入和醋酸甲羟孕酮注射液。没有人愿意接受曼月乐。各种LARC方法的可接受性按0至10分的可接受性评分进行衡量。对于铜宫内节育器、依伴侬和醋酸甲羟孕酮注射液,可接受性评分分别为10分的比例为50%、40.17%和25%。
关于现有LARC方法的益处和安全性仍存在知识差距。为提高LARC方法的广泛覆盖和更高的可接受性,应考虑医护人员的参与以及在避孕咨询中增加皮下埋植剂。